StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) stock

RGCNasdaqMedicinal Chemicals & Botanical Products
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.69+0.14 (+3.08%)

Close on Nov 18, 2026Market cap $2.33BP/E –Yield –

Regencell Bioscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Regencell Bioscience's market cap was $2.68B on Nov 11, 2026, against $5.70B a year earlier. Over the last 5 years it ranged from $43.71M to $14.45B, with a median of $350.02M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.68B-74.2%
2025Dec 31, 2025$10.38B+16053.8%
2024Dec 31, 2024$64.28M-52.9%
2023Dec 29, 2023$136.63M-62.4%
2022Dec 30, 2022$362.91M+13.9%
2021Dec 31, 2021$318.52M–

More Regencell Bioscience figures

See a number that looks wrong?